{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:10:53Z","timestamp":1789157453720,"version":"build-2803163510"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.neubiorev.2021.10.008","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T11:57:40Z","timestamp":1634126260000},"page":"899-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["What substance P might tell us about the prognosis and mechanism of Parkinson's disease?"],"prefix":"10.1016","volume":"131","author":[{"given":"Paola","family":"Tirassa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Raspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-0421","authenticated-orcid":false,"given":"Massimo","family":"Ralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-7607","authenticated-orcid":false,"given":"Antonella","family":"Polimeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Possenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-704X","authenticated-orcid":false,"given":"Cinzia","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2021.10.008_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00008877-199406000-00017","article-title":"Conditioned place aversion produced by microinjections of substance P into the periaqueductal gray of rats","volume":"5","author":"Aguiar","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0010","first-page":"52","article-title":"Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK\/Erk activation: evidence for the involvement of the delayed rectifier potassium current","author":"Amadoro","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2990.2008.00937.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of parkinson\u2019s disease","volume":"34","author":"Attems","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0020","doi-asserted-by":"crossref","DOI":"10.4103\/1673-5374.270297","article-title":"Locus coeruleus-norepinephrine: basic functions and insights into Parkinson\u2019s disease","author":"Bari","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-5193(86)80206-5","article-title":"Substance P and Parkinson\u2019s disease: a causal relationship?","volume":"120","author":"Barker","year":"1986","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00207458908991613","article-title":"Adrenal grafting for parkinson\u2019s disease: a role for substance P","volume":"46","author":"Barker","year":"1989","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(13)70047-4","article-title":"Changing the research criteria for the diagnosis of Parkinson\u2019s disease: obstacles and opportunities","author":"Berg","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(94)90534-7","article-title":"Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra","volume":"668","author":"Bing","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","article-title":"\u03b1-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects","volume":"32","author":"Bloch","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1468-1331.2008.02148.x","article-title":"Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study","volume":"15","author":"Bohnen","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(92)91674-4","article-title":"The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats","volume":"592","author":"Boix","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0169-328X(87)90031-3","article-title":"A cDNA encoding the precursor of the rat neuropeptide, neurokinin B","volume":"2","author":"Bonner","year":"1987","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0070","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0075","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27556","article-title":"Gut\u2013brain axis and the spread of \u03b1-synuclein pathology: vagal highway or dead end?","author":"Breen","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0006-8993(80)91293-7","article-title":"Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig","volume":"191","author":"Brimijoin","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0090","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1460-9568.2003.02600.x","article-title":"Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain","volume":"17","author":"Caberlotto","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078036","article-title":"Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels","volume":"8","author":"Campolongo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2012.04.028","article-title":"Substance P-induced changes in cell genesis following diffuse traumatic brain injury","volume":"214","author":"Carthew","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.brainres.2018.01.011","article-title":"Enteric nervous system manifestations of neurodegenerative disease HHS Public Access","volume":"1693","author":"Chalazonitis","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0110","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1073\/pnas.1320827111","article-title":"Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices","volume":"111","author":"Chandler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0115","doi-asserted-by":"crossref","DOI":"10.1186\/2047-9158-4-1","article-title":"Meta-analyses on prevalence of selected Parkinson\u2019s nonmotor symptoms before and after diagnosis","volume":"4","author":"Chen","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170210","article-title":"The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities","author":"Chen","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0125","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.neuropharm.2011.08.027","article-title":"Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt\/PKB cell signaling pathway","volume":"61","author":"Chu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90529-5","article-title":"Substance P-like immunoreactivity in brains with pathological features of Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"486","author":"Clevens","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0135","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1523\/JNEUROSCI.12-09-03392.1992","article-title":"A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin","volume":"12","author":"Crawford","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0167-0115(93)90026-5","article-title":"Organization of substance P primary sensory neurons: ultrastructural and physiological correlates","volume":"46","author":"Cuello","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neures.2007.10.007","article-title":"Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats","volume":"60","author":"Cui","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0306-4522(93)90026-C","article-title":"Distribution and co-localization of 5-hydroxytryptamine, thyrotropin-releasing hormone and substance p in the cat medulla","volume":"57","author":"Dean","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0160","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1073\/pnas.190276697","article-title":"The proliferative and antiapoptotic effects of substance P are facilitated by formation of a \u03b2-arrestin-dependent scaffolding complex","volume":"97","author":"DeFea","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia","author":"Del Tredici","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0170","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.4049\/jimmunol.164.5.2479","article-title":"Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance P","volume":"164","author":"Dimri","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0175","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.124.3.1009","article-title":"Impaired efficacy of cough in patients with Parkinson disease","volume":"124","author":"Ebihara","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0180","series-title":"Amino Acids. Amino Acids","first-page":"251","article-title":". The role of substance P in stress and anxiety responses","author":"Ebner","year":"2006"},{"issue":"80","key":"10.1016\/j.neubiorev.2021.10.008_bib0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.6171884","article-title":"Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions","volume":"215","author":"Eison","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-8993(86)90691-8","article-title":"Behavioural effects of tachykinins and related peptides","volume":"381","author":"Elliott","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0195","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-4-43","article-title":"Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions","volume":"4","author":"Elstner","year":"2011","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3940(92)90014-X","article-title":"Striatal neuropeptide levels in Parkinson\u2019s disease patients","volume":"145","author":"Fernandez","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0210","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/119.3.823","article-title":"Alterations in peptide levels in Parkinson\u2019s disease and incidental Lewy body disease","volume":"119","author":"Fernandez","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cne.903340110","article-title":"Peripheral peptidergic fibers of the trigeminal nerve in the olfactory bulb of the rat","volume":"334","author":"Finger","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cne.902940212","article-title":"Ultrastructure of substance P\u2010 and CGRP\u2010immunoreactive nerve fibers in the nasal epithelium of rodents","volume":"294","author":"Finger","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(95)00313-A","article-title":"Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice","volume":"283","author":"Fornai","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-3565(24)37011-9","article-title":"Effects of noradrenergic lesions on MPTP\/MPP+ kinetics and MPTP- induced nigrostriatal dopamine depletions","volume":"283","author":"Fornai","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0168-0102(89)90018-7","article-title":"Substance P immunoreactivity in the vagal nerve of mice","volume":"7","author":"Funakoshi","year":"1989","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00515591","article-title":"Substance P in the vagus nerve - Immunochemical and immunohistochemical evidence for axoplasmic transport","volume":"306","author":"Gamse","year":"1979","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0245","first-page":"1247","article-title":"Substance P: structural requirements for the activation of brain catecholamine synthesis and locomotor activity in rats","volume":"33","author":"Garcia Sevilla","year":"1983","journal-title":"Arzneimittel-Forschung\/Drug Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0250","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0255","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.1114275108","article-title":"Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer","volume":"108","author":"Gillespie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0260","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0265","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(93)90813-3","article-title":"Effect of substance P on acetylcholine and dopamine release in the rat striatum: a microdialysis study","volume":"622","author":"Guevara Guzman","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0091-3057(92)90062-K","article-title":"The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release","volume":"41","author":"Hall","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0280","unstructured":"Hargreaves, R., n.d. Imaging substance P receptors (NK1) in the living human brain using positron emission tomography - PubMed [WWW Document]. URL https:\/\/pubmed.ncbi.nlm.nih.gov\/12562139\/ (accessed 6.21.21)."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/S1357-2725(01)00031-0","article-title":"Substance P","author":"Harrison","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0290","doi-asserted-by":"crossref","DOI":"10.3109\/15622970309167952","article-title":"Substance P and substance P receptor antagonists in the pathogenesis and treatment of affective disorders","author":"Herpfer","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0295","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11307-005-7001-6","article-title":"Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain","volume":"7","author":"Hietala","year":"2006","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0300","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of \u03b1-synuclein aggregation in the nervous system","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0305","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0310","article-title":"Distribution of substance P in brain and periphery and its possible role as a co-transmitter","author":"H\u00f6kfelt","year":"1982","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0315","doi-asserted-by":"crossref","DOI":"10.1016\/S0028-3908(00)00010-1","article-title":"Neuropeptides - an overview","author":"H\u00f6kfelt","year":"2000","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/0167-0115(95)00019-8","article-title":"Tachykinin receptors in gastrointestinal motility","author":"Holzer-Petsche","year":"1995","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0325","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0330","series-title":"An Introduction to Pain and Its Relation to Nervous System Disorders","first-page":"317","article-title":"Pain in the brain","author":"Iannitelli","year":"2016"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0335","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0304-3940(89)90552-1","article-title":"Trophic effect of various neuropeptides on the cultured ventral spinal cord of rat embryo","volume":"101","author":"Iwasaki","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0340","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1471-4159.1986.tb00793.x","article-title":"Lack of change in basal ganglia neuropeptide content following subacute 1\u2010Methyl\u20104\u2010Phenyl\u20101,2,3,6\u2010tetrahydropyridine treatment of the common marmoset","volume":"47","author":"Jenner","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0345","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0006-8993(78)91104-6","article-title":"Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study","volume":"152","author":"Jessel","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0350","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/0306-4522(82)90113-0","article-title":"Substance P modifies the 6-hydroxydopamine induced alteration of postnatal development of central noradrenaline neurons","volume":"7","author":"Jonsson","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0355","first-page":"179","article-title":"Effect of substance P on neonatally axotomized noradrenaline neurons in rat brain","volume":"61","author":"Jonsson","year":"1983","journal-title":"Med. Biol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0360","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jnr.490300309","article-title":"Immunohistochemical evidence for the coexistence of substance P, thyrotropin\u2010releasing hormone, GABA, methionin\u2010enkephalin, and leucin\u2010enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat","volume":"30","author":"Kachidian","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0365","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of \u03b1-synuclein staging","volume":"34","author":"Kalaitzakis","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0370","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0375","first-page":"403","article-title":"Substance P modulation of the mesolimbic dopamine system","volume":"192","author":"Kalivas","year":"1985","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-0115(01)00264-6","article-title":"Regulation of apoptosis by somatostatin and substance P in peritoneal macrophages","volume":"101","author":"Kang","year":"2001","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0385","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/cne.901930216","article-title":"Substance P in the vagal sensory ganglia: localization in cell bodies and pericellular arborizations","volume":"193","author":"Katz","year":"1980","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0390","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0143-4179(98)90080-4","article-title":"Substance P fragments and striatal endogenous dopamine outflow: interaction with substance P","volume":"32","author":"Khan","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0395","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01057812","article-title":"Activating effect of substance P on nerve tissue in culture","volume":"18","author":"Kozlova","year":"1986","journal-title":"Neurophysiology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0400","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4522(99)00400-5","article-title":"Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats","volume":"95","author":"Krasnova","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0410","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1073\/pnas.84.3.881","article-title":"Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc","volume":"84","author":"Krause","year":"1987","journal-title":"Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0415","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/BF00841710","article-title":"Effect of substance P on an experimental parkinsonian syndrome","volume":"108","author":"Kryzhanovskii","year":"1989","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0420","doi-asserted-by":"crossref","DOI":"10.1007\/BF00787735","article-title":"[Effects of intranasally administered substance P in parkinsonian syndrome] - PubMed [WWW Document]","author":"Kryzhanovski\u012d","year":"1992","journal-title":"Biull. Eksp. Biol. Med."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0425","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1119(02)00861-2","article-title":"Identification, localization and receptor characterization of novel mammalian substance P-like peptides","volume":"296","author":"Kurtz","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0430","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneumeth.2007.10.004","article-title":"Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions","volume":"168","author":"Lai","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0435","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1471-4159.2003.02014.x","article-title":"Substance P protects spiral ganglion neurons from apoptosis via PKC-Ca 2+-MAPK\/ERK pathways","volume":"87","author":"Lallemend","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0440","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease modification in parkinson\u2019s disease: current approaches, challenges, and future considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0445","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14802\/jmd.15003","article-title":"Many faces of parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease","volume":"8","author":"Lee","year":"2015","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0450","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14802\/jmd.18037","article-title":"Cognition, olfaction and uric acid in early de novo Parkinson\u2019s disease","volume":"11","author":"Lee","year":"2018","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0455","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00241","article-title":"Investigation of behavioral dysfunctions induced by monoamine depletions in a mouse model of Parkinson\u2019s disease","volume":"12","author":"Li","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0460","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00247354","article-title":"Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation","volume":"74","author":"Lindefors","year":"1989","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0465","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and Parkinson disease A Swedish register-based matched-cohort study)","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0016-5085(79)90006-4","article-title":"Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve","volume":"77","author":"Lundberg","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0475","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/j.1471-4159.1987.tb05738.x","article-title":"Substance P synthesis and transport in explants of nodose Ganglion\/Vagus nerve: effects of double ligation, 2\u2010Deoxyglucose, veratridine, and ouabain","volume":"48","author":"MacLean","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0480","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1991.tb33114.x","article-title":"Substance P and the inflammatory and immune response","volume":"632","author":"Mantyh","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0485","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-2999(93)90489-5","article-title":"Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice","volume":"236","author":"Marien","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0490","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.neuropharm.2011.12.025","article-title":"Substance P activates ADAM9 mRNA expression and induces \u03b1-secretase-mediated amyloid precursor protein cleavage","volume":"62","author":"Marolda","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0495","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0028-3908(92)90037-P","article-title":"Behavioural consequences following infusion of selective neurokinin agonists into the median raphe nucleus of the rat","volume":"31","author":"Mason","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0500","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0505","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","article-title":"Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson\u2019s disease","volume":"41","author":"Mavridis","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2019.06.009","article-title":"Locus coeruleus-norepinephrine modulation of sensory processing and perception: a focused review","author":"McBurney-Lin","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0515","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","article-title":"Increased M-calpain expression in the mesencephalon of patients with Parkinson\u2019s disease but not in other neurodegenerative disorders involving the mesencephalon: A role in nerve cell death?","volume":"73","author":"Mouatt-Prigent","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0520","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of substance P and the NK-1 receptor in human pathology","volume":"46","author":"Mu\u00f1oz","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0525","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0006-8993(84)90317-2","article-title":"Accelerated regeneration of central catecholamine fibers in cat occipital cortex: effects of substance P","volume":"323","author":"Nakai","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0530","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(96)00625-2","article-title":"Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study","volume":"78","author":"Nalivaiko","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0535","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0028-3908(84)90234-X","article-title":"Locomotor activation induced in rodents by substance P and analogues. Blockade of the effect of substance P by met-enkephalin antiserum","volume":"23","author":"Naranjo","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0540","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1471-4159.1978.tb10462.x","article-title":"Stimulatory effects of substance P on neurite extension and cyclic amp levels in cultured neuroblastoma cells","volume":"30","author":"Narumi","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0545","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-4522(92)90401-M","article-title":"Serotonin-, substance P- and glutamate\/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate","volume":"48","author":"Nicholas","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-4328(94)90024-8","article-title":"Contribution of the vagus nerve in mediating the memory-facilitating effects of substance P","volume":"62","author":"Nogueira","year":"1994","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0555","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.20061","article-title":"The role of substance P in inflammatory disease","author":"O\u2019Connor","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0560","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12031-020-01669-7","article-title":"Integrative analysis of gene expression and regulatory network interaction data reveals the protein kinase C family of Serine\/Threonine receptors as a significant druggable target for Parkinson\u2019s disease","volume":"71","author":"Odumpatta","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0565","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0014-2999(90)90049-C","article-title":"Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson\u2019s disease","volume":"182","author":"Orosz","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0570","series-title":"Handbook of Biologically Active Peptides","first-page":"943","article-title":"Tachykinins, chapter 125","author":"Page","year":"2013"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0575","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00435","article-title":"The noradrenergic system in Parkinson\u2019s disease","author":"Paredes-Rodriguez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0580","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3171\/JNS-07\/09\/0593","article-title":"Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions","volume":"107","author":"Park","year":"2007","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0585","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0608-5","article-title":"Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration","volume":"13","author":"Pellegrini","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0590","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0028-3908(86)90196-6","article-title":"Stimulatory effect of substance P on the spontaneous release of newly synthesized [3H]dopamine from rat striatal slices: a tetrodotoxin-sensitive process","volume":"25","author":"Petit","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0595","article-title":"Systemic activation of Nrf2 pathway in Parkinson\u2019s disease","author":"Petrillo","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0600","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1212\/WNL.34.4.516","article-title":"Methionine- enkephalin, substance p, and homovanillic acid in the CSF of parkinsonian patients","volume":"34","author":"Pezzoli","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0605","first-page":"2374","article-title":"Immunocytochemical localization of neuronal antigens: tyrosine hydroxylase, substance P, [Met5]-enkephalin","volume":"38","author":"Pickel","year":"1979","journal-title":"Fed. Proc."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0610","doi-asserted-by":"crossref","DOI":"10.1152\/jn.00436.2005","article-title":"AMPA receptors are modulated by tachykinins in rat cerebellum neurons","volume":"94","author":"Pieri","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0615","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/303714a0","article-title":"Autoradiographic distribution of substance P receptors in rat central nervous system","volume":"303","author":"Quirion","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0620","doi-asserted-by":"crossref","DOI":"10.1016\/0165-0173(90)90003-7","article-title":"The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings","author":"Reiner","year":"1990","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0625","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","article-title":"The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases","volume":"109","author":"Rey","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0630","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1054\/npep.2000.0834","article-title":"Neuroanatomical localisation of substance P in the CNS and sensory neurons","volume":"34","author":"Ribeiro-da-Silva","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0635","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0640","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1037\/0033-2909.133.6.1007","article-title":"Substance P at the Nexus of mind and body in chronic inflammation and affective disorders","volume":"133","author":"Rosenkranz","year":"2007","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2020.03.034","article-title":"Vagus nerve stimulation and Neurotrophins: a biological psychiatric perspective","author":"Rosso","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0650","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1460-9568.1996.tb01318.x","article-title":"Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia","volume":"8","author":"Salin","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0655","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1124\/mol.105.015453","article-title":"Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism","volume":"68","author":"Salthun-Lassalle","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0660","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0665","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cne.10143","article-title":"Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli","volume":"444","author":"Schaefer","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0670","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamaneurol.2016.4467","article-title":"Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations a randomized clinical trial","volume":"74","author":"Schapira","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0675","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrn.2017.91","article-title":"Erratum: non-motor features of Parkinson disease (Nature Reviews Neuroscience (2017) 18 (435-450) DOI: 10.1038\/nrn.2017.62)","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0680","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mds.26620","article-title":"Early synaptic dysfunction in Parkinson\u2019s disease: insights from animal models","volume":"31","author":"Schirinzi","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0685","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28458","article-title":"Serum substance P is increased in Parkinson\u2019s disease and correlates with motor impairment","author":"Schirinzi","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0690","article-title":"CSF \u03b1-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients","author":"Schirinzi","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0695","article-title":"COVID-19: dealing with a potential risk factor for chronic neurological disorders","author":"Schirinzi","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0700","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26415","article-title":"New clinical trials for nonmotor manifestations of Parkinson\u2019s disease","author":"Schrag","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0705","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00386","article-title":"Substance P saliva reduction predicts pharyngeal dysphagia in Parkinson\u2019s disease","volume":"10","author":"Schr\u00f6der","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2015.09.039","article-title":"Organization of the locus coeruleus-norepinephrine system","author":"Schwarz","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0715","doi-asserted-by":"crossref","DOI":"10.1124\/pr.54.2.285","article-title":"The tachykinin peptide family","volume":"54","author":"Severini","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0720","doi-asserted-by":"crossref","DOI":"10.2174\/1567205013666160401114039","article-title":"Substance P and Alzheimer\u2019s disease: emerging novel roles","volume":"13","author":"Severini","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0725","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s Disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0730","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2009.02.006","article-title":"Regional differences in the severity of Lewy body pathology across the olfactory cortex","volume":"453","author":"Silveira-Moriyama","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0735","doi-asserted-by":"crossref","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0740","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0143-4179(91)90148-C","article-title":"Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem Parkinsonian brains","volume":"18","author":"Sivam","year":"1991","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0745","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cne.903330405","article-title":"Immunohistochemical analyses of the human olfactory bulb","volume":"333","author":"Smith","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0750","doi-asserted-by":"crossref","DOI":"10.1053\/eujp.2000.0171","article-title":"Substance P","author":"Snijdelaar","year":"2000","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0755","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0197-0186(82)90059-6","article-title":"Influence of peptides on 3H-dopamine release from superfused rat striatal slices","volume":"4","author":"Starr","year":"1982","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0760","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0016-5085(89)90070-X","article-title":"Expression of substance P\/neurokinin A-encoding preprotachykinin messenger ribonucleic acids in the rat enteric nervous system","volume":"97","author":"Sternini","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0765","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0770","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1111\/febs.14607","article-title":"Determinants of dopaminergic neuron loss in Parkinson\u2019s disease","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0775","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","article-title":"Parkinson\u2019s disease is not simply a prion disorder","volume":"37","author":"Surmeier","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0780","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0785","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1471-4159.1992.tb09430.x","article-title":"Ligand binding kinetics of substance P and neurokinin a receptors stably expressed in Chinese Hamster ovary cells and evidence for differential stimulation of inositol 1,4,5\u2010trisphosphate and cyclic AMP second messenger responses","volume":"59","author":"Takeda","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0790","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0306-4522(96)00198-4","article-title":"Increased level of neurokinin-1 tachykinin receptor gene expression during early postnatal development of rat brain","volume":"74","author":"Taoka","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0795","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(84)90217-8","article-title":"Substance P immunoreactivity in the post-mortem parkinsonian brain","volume":"303","author":"Tenovuo","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0800","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034138","article-title":"Treatment with a substance p receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early parkinson\u2019s disease","volume":"7","author":"Thornton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0805","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neulet.2010.06.057","article-title":"A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death","volume":"481","author":"Thornton","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0810","article-title":"Cholecystokinin-8 and nerve growth factor: two endogenous molecules working for the upkeep and repair of the nervous system","author":"Tirassa","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0815","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0167-0115(83)90292-6","article-title":"Modulation of locomotor activity by substance P in rats","volume":"5","author":"Treptow","year":"1983","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0820","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-010-0687-9","article-title":"\u03b1-Synucleinopathy in the human olfactory system in Parkinson\u2019s disease: involvement of calcium-binding protein- and substance P-positive cells","volume":"119","author":"Ubeda-Ba\u00f1on","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0825","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0257-5","article-title":"Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve","volume":"13","author":"Uemura","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0830","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-016-1661-y","article-title":"Brain-to-stomach transfer of \u03b1-synuclein via vagal preganglionic projections","volume":"133","author":"Ulusoy","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0835","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts","volume":"72","author":"v. Euler","year":"1931","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0840","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF02450276","article-title":"Cellule enterocromaffini e cellule basigranulose acidofile nei Vertebrati","volume":"19","author":"Vialli","year":"1933","journal-title":"Z Zellforschg mikr Anatomie"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0845","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.27776","article-title":"Neuromelanin, aging, and neuronal vulnerability in Parkinson\u2019s disease","volume":"34","author":"Vila","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0850","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0855","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3174\/ajnr.A2350","article-title":"Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease","volume":"32","author":"Wang","year":"2011","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0860","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.3892\/mmr.2015.4464","article-title":"Substance P prevents 1-methyl-4-phenylpyridiniuminduced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.08.032","article-title":"The locus coeruleus-norepinephrine system and sensory signal processing: a historical review and current perspectives","author":"Waterhouse","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0870","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-4522(88)90249-7","article-title":"Immunocytochemical studies on the basal ganglia and substantia nigra in parkinson\u2019s disease and huntington\u2019s Chorea","volume":"25","author":"Waters","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0875","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0361-9230(91)90232-9","article-title":"Substance P injections into the ventral tegmentum affect unit activity in mesolimbic terminal regions","volume":"26","author":"West","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0880","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3940(93)90877-N","article-title":"Neurotrophic effects of substance P on hippocampal neurons in vitro","volume":"164","author":"Whitty","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0885","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.22464","article-title":"Biopsies of olfactory epithelium in patients with Parkinson\u2019s disease","volume":"24","author":"Witt","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0890","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0895","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.expneurol.2015.05.007","article-title":"Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"271","author":"Yang","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0900","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2015.08.032","article-title":"Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson\u2019s disease","volume":"1625","author":"Yao","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2021.10.008_bib0905","article-title":"Using gelatin nanoparticle mediated intranasal delivery of neuropeptide substance P to enhance neuro-recovery in hemiparkinsonian rats","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS One"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763421004504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763421004504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:14:50Z","timestamp":1758968090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763421004504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":181,"alternative-id":["S0149763421004504"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.008","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What substance P might tell us about the prognosis and mechanism of Parkinson's disease?","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}